The short answer
The name HPUS Rauwolfia serpentina is not enough to establish a low-blood-pressure or sedation interaction with ropinirole. Have a pharmacist inspect the exact product and potency before use; conventional reserpine doses cannot be assumed from a homeopathic label.
What this answer covers
HPUS-labelled Rauwolfia serpentina preparations. One oral 6X-and-higher liquid is an identification example, not a match to every potency or product.
- Supplement or preparation
- HPUS_Rauwolfia serpentina
- Medication ingredient
- ropinirole
What the inspected label says
One current DailyMed entry describes an oral Rauwolfia serpentina homeopathic liquid at 6X and higher potencies. It does not give an assayed reserpine dose. Your product may have a different potency or formulation.
Why conventional Rauwolfia evidence does not settle this
A plant name or homeopathic potency does not tell us that the product delivers the same exposure as a conventional botanical extract or purified drug. The inspected label cannot establish a specific additive blood-pressure or sedating effect with ropinirole.
What to bring to the pharmacist
Bring the complete bottle or a clear copy of its label, including potency, directions and inactive ingredients. The example liquid lists an alcohol vehicle; the amount actually taken matters, so its presence alone does not quantify an interaction.
Symptoms deserve attention regardless of the cause
Ropinirole can cause dizziness on standing, fainting and sleepiness. Report new symptoms promptly. Do not drive if you are drowsy or have unexpected sleep episodes, and let the treating team decide whether treatment needs changing.
Evidence and practical considerations
Side effects & toxicity
The available HPUS product label does not establish an active reserpine exposure or a ropinirole interaction; product-specific review is needed.
- Exact scope
- HPUS-labelled Rauwolfia serpentina preparations. One oral 6X-and-higher liquid is an identification example, not a match to every potency or product. with Oral immediate-release ropinirole; hydrochloride salt expressed as equivalent free base in the inspected label.
- Medication form and route
- oral ropinirole; supplement preparation and route described in scope
- Timing or duration
- No exact-pair safe duration or protective spacing interval established.
What remains uncertain
- Homeopathic potency is not an assayed reserpine dose. Neither safety nor pharmacologically active exposure can be inferred for every product under this node.
Factors that may matter: exact HPUS potency; formulation and alcohol vehicle.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral immediate-release ropinirole tablets for Parkinson disease or primary restless legs syndrome.
Ropinirole can cause somnolence, sudden sleep episodes and orthostatic hypotension. Concomitant sedating medicines or alcohol can increase sleepiness risk. CYP1A2 is its major metabolic enzyme; inhibitors and inducers may alter clearance. Ciprofloxacin increased exposure, whereas theophylline did not. Cigarette smokers had lower dose-normalized exposure than nonsmokers in a small RLS comparison.
How this applies: Exact oral ropinirole risk and metabolic context; section 11 justifies hydrochloride-to-free-base active-moiety identity only.
None of these ten supplement pairs is directly tested in this label. Cigarette smoking is not interchangeable with oral cannabis or isolated CBD; ciprofloxacin results are not caffeine results. No extended-release kinetic equivalence assumed.
Source 2: official product information or herbal guidance
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Users of one homeopathic oral liquid.
Label identifies homeopathic potency and states claims are based on traditional practice rather than accepted medical evidence. It supplies no assayed reserpine dose.
How this applies: Product identification only. Conventional reserpine or root-dose evidence is not transferred to this homeopathic product.
One product is not the whole HPUS_Rauwolfia inventory node. Label cannot establish absence or pharmacologic quantity of alkaloids; no ropinirole interaction measurement.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources inspected and exact current claim adjudicated; no clinical review asserted. | |
| Research summary published |
Article revision: d324b971b89d43d4
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.